Genetics Generation Advancement Corp. (TPEX:4160)

Taiwan · Delayed Price · Currency is TWD

33.40

-0.85 (-2.48%)

Nov 6, 2026, 1:30 PM CST

Market Cap	935.66M -36.8%
Revenue (ttm)	614.42M +0.1%
Net Income	17.93M -44.1%
EPS	0.64 -44.2%
Shares Out	28.01M
PE Ratio	52.31
Forward PE	n/a
Dividend	1.76 (5.27%)
Ex-Dividend Date	Oct 3, 2025

Volume	101,195
Open	34.15
Previous Close	34.25
Day's Range	32.00 - 34.15
52-Week Range	32.00 - 54.31
Beta	0.36
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About TPEX:4160

Genetics Generation Advancement Corp. engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan. The company offers testing services, such as pre-implantation, prenatal stage, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology, neonatology and pediatrics, oncology, and medical research services. It also provides AI and data applications, such as bioinformatic, materials sciences, research and d... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2008

Employees 104

Stock Exchange Taipei Exchange

Ticker Symbol 4160

Full Company Profile

Financial Performance

In 2025, TPEX:4160's revenue was 603.11 million, a decrease of -8.88% compared to the previous year's 661.86 million. Earnings were 21.37 million, a decrease of -60.93%.

Financial Statements